Market Summary: The naloxone spray market is anticipated to experience a value growth rate of 22.8% from 2020, reaching USD 1.41 Billion by 2028. Naloxone Nasal Spray is utilized to address opioid emergencies or potential opioid overdoses displaying symptoms like breathing difficulties and severe drowsiness or unresponsiveness.
Naloxone Nasal Spray is designed to temporarily reverse the effects of opioid medications, without impacting individuals not exposed to opioids. After administering the first dose of the nasal spray, it is crucial to seek emergency medical assistance for the patient. According to the Centers for Disease Control and Prevention, approximately 400,000 people died from opioid overdoses between 1999 and 2017, with over 130 daily opioid-related deaths in America on average. This category includes prescription drugs like Oxycodone, fentanyl, morphine, and hydrocodone, as well as illegal substances such as heroin.
Get a sample copy of the Naloxone Spray Market report: https://www.reportsanddata.com/download-free-sample/1362
The market is expected to witness significant growth due to increased product launches and approvals for new naloxone spray variants. For example, in April 2020, Pfizer introduced a generic nasal spray of naloxone, expected to drive market demand significantly.
Efforts are being made to enhance the availability of emergency naloxone overdose reversal medication, given the rising prevalence of opioid overdoses. The FDA is assisting manufacturers in obtaining approval for over-the-counter naloxone spray products, exploring avenues to make naloxone more accessible in communities.
Key Report Coverage:
Regional and country-wise naloxone spray statistics from 2018-2028, using 2016 & 2017 as historical data and considering 2020 as the base year.
Market size estimation, historical and forecasted trend analysis.
Analysis of various nasal spray dosages and their individual market shares.
Healthcare regulatory frameworks in each region.
Regional opioid overdose outlook.
Ongoing clinical trials and developments.
Mapping of regional naloxone spray prevalence.
Competitive landscape analysis, including pricing strategies of key industry players.
Recommendations for new market entrants.
Market trends, including drivers, constraints, opportunities, threats, challenges, investment opportunities, and recommendations.
Strategic recommendations for key business segments based on market estimations.
Company profiling with detailed strategies, financials, and recent developments.
Salient Trends of the Naloxone Spray Market:
Projected growth of the naloxone spray market at a rate of 22.8%, reaching USD 1.41 Billion by 2028.
FDA approval for Narcan nasal spray of naloxone in November 2015, available without a prescription in 17 US states.
FDA approval for NARCAN Nasal Spray 2 mg formulation in January 2017.
Availability of nasal spray at a discounted price of USD 37.50 per dose for specific entities since 2015.
Emergent BioSolutions' acquisition of Adapt Pharma for USD 635.0 million upfront and potential sales-based milestones.
Companies Considered and Profiled:
Emergent BioSolutions, Pfizer, and Teva Pharmaceuticals Industries Ltd.
Market-O-Nomics:
Naloxone Spray market valuation was USD 273.2 Million in 2020, expected to reach USD 1.41 Billion by 2028.
Clinics estimated to dominate the market after hospitals, with a projected growth rate of 22.7%.
Asia Pacific expected to have the highest growth rate of 25.2%.
Significant growth anticipated in the European naloxone spray market due to increasing product approvals.
The US dominates the North American market, facing an opioid crisis classified as a Public Health Emergency in 2017.
FDA approval for Teva Pharmaceutical Industries Ltd. to market generic naloxone nasal spray in April 2020.
Challenges and Hindrances:
High costs associated with naloxone and potential serious side-effects may impede market growth.
Segments Covered in the Report:
Dosage Outlook (Revenue, USD Million; 2018-2028): 2 mg/actuation, 4 mg/actuation.
Distribution Channel Outlook (Revenue, USD Million; 2018-2028): Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, Others.
Regional Outlook (Revenue, USD Million; 2018-2028): North America (U.S.), Europe (UK, France), Asia Pacific (China, India, Japan), Latin America (Brazil), MEA.
Explore Trending Reports:
Polyamide Market-https://www.reportsanddata.com/report-detail/polyamide-market
Recycled Plastics Market-https://www.reportsanddata.com/report-detail/recycled-plastics-market
Propylene Oxide Market-https://www.reportsanddata.com/report-detail/propylene-oxide-market
Cellulose Ether Market-https://www.reportsanddata.com/report-detail/cellulose-ether-market
Logistics Automation Market-https://www.reportsanddata.com/report-detail/logistics-automation-market
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/1362
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release